Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. Verdun
Observed names:
E Verdun,
E. VERDUN,
VERDUN E
OpenAlex ID:
A5154964068
The Independent Comparison of Interferon (INCOMIN) trial: A multicenter randomized trial comparing clinical and MRI efficacy of IFN beta-1a and beta-1b in multiple sclerosis
2001
·
DURELLI, Luca
, BERGUI, Mauro
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
·
4
Interferon-beta-1b in multiple sclerosis: comparing two different doses (the OPTIMS Study)
2004
·
DURELLI, Luca
, CLERICO, Marinella
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
·
2
Reducing interferon beta dose in chronically-treated ms patients may have long-term deleterious effects on disease activity
2003
·
DURELLI, Luca
, P. BARBERO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
·
1
The optims study. I looking for a treatment response marker
2005
·
DURELLI, Luca
, VERSINO, Elisabetta
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Looking for treatment response indicator. real- time rt-pcr determination of mrna levels of cytokine, chemokine and chemokine receptors in Multiple Sclerosis patients treated with ifn beta 1b: correlation with mri response
2005
·
CUCCI, Marie Angele
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Risk of cancers in patients with myasthenia gravis treated with immuno-suppressive treatments: the experience of torino university centre
2005
·
A. PIPIERI
, B. FERRERO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Assessing treatment response to immunomodulatory drugs for ms: a single active mri scan after 6 months of treatment is the best indicator of persisting disease activity
2005
·
DURELLI, Luca
, VERSINO, Elisabetta
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
IFN beta-1b 500 mcg every-other-day, subcutaneously in MS patients. Tolerability, clinical and MRI results after one year of treatment
2005
·
CLERICO, Marinella
, A. Pipaeri
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Ischaemic stroke due to post-chemiotherapy embolism: case report
2005
·
B. FERRERO
, E. VERDUN
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Autoimmunity profile in interferon beta- 1a treated Multiple Sclerosis patients. the auprin study: comparison of 2 different dosage of subcutaneous interferon-beta 1a
2005
·
E. VERDUN
, L. GIORDANO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Best indicator of persisting disease activity
2005
·
DURELLI, Luca
, VERSINO, Elisabetta
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Mxa protein in ms patients treated with different doses of ifn beta-1b (the optims study): correlation with treatment response, ifn beta dose, and neutralizing antibodies (nab)occurrence
2005
·
A. RICCI
, L. GIORDANO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
IFN beta-1b in multiple sclerosis: comparing two different doses (the Optims Study).
2004
·
E. VERDUN
, P. BARBERO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Mxa protein and interleukin-10 (il-10) leukocyte production and anti-ifn neutralizing antibody(nab) occurrence in relapsing remitting multiple sclerosis (rrms) patients treated with different doses of interferon (ifn) beta- 1b
2004
·
CLERICO, Marinella
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Autoimmunity profile in interferon beta- 1a treated multiple sclerosis patients. the auprin study: comparision of 2 different dosage of subcutaneous interferon-beta 1a.
2004
·
E. VERDUN
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Every-other-day interferon beta-1b compared with once-weekly interferon beta-1a in MS. Further analysis of treatment effect on MR1 activity and neutralising antibodies (NAbs) in the INCOMIN Trial
2004
·
P. Barbero
, A. Ricci
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Every-other-day interferon beta-1b compared with once weekly interferon beta 1-a in ms. further analysis of treatment effect on mri activity and neutralizing antibodies (nabs) in the INCOMIN trial
2004
·
P. BARBERO
, M. BERGUI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Testing a high-dose protocol (500 mcg every-other-day, subcutaneously) for interferon beta-1b treatment of ms. Clinical and laboratory tolerability evaluated in a multicentre study
2003
·
DURELLI, Luca
, G. GIULIANI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
La dose ottimale di interferone beta: studio preliminare sulla tolleranza della dose di 375 microgrammi di interferone beta-1b
2003
·
E. VERDUN
, P. B.A.R.B.E.R.O. A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Reduction Dose Study 1 Year After.
2003
·
P. BARBERO
, M. BERGUI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Anti-TR antibodies positive cerebellar syndrome as the presentation symptom of a case of Hodgkin’s disease (HD).
2003
·
CLERICO, Marinella
, E. ROTA
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Blood Hypertension During Mitoxantrone Treatment of a Multiple Sclerosis Patient
2003
·
P. BARBERO
, E. VERDUN
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Correlation of anti-interferon beta neutralising antobodies with clinical response and mri activity in the INCOMIN (independent comparison of interferon) trial.
2003
·
P. BARBERO
, E. VERDUN
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Evaluation of high-dose interferon beta-1b in relapsing-remitting ms non-responder patients: the optims trial. safety data.
2003
·
E. VERDUN
, A. RICCI
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Secondary progressive (sp) ms: immunological effects of intravenous immunoglobuln g (ivig) therapy
2003
·
A. RICCI
, A. OGGERO
, et al.
·
Institutional Research Information System University of Turin (University of Turin)
Show more works
View as search
Works count:
33
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type